Early Presence Of Antiangiogenesis-Related Adverse Events As A Potential Biomarker Of Antitumor Efficacy In Patients With Metastatic Gastric Cancer Treated With Apatinib.
JOURNAL OF CLINICAL ONCOLOGY（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要